Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$101.05 - $133.57 $1.35 Million - $1.79 Million
13,396 New
13,396 $1.4 Million
Q3 2023

Nov 07, 2023

BUY
$128.91 - $192.44 $355,920 - $531,326
2,761 New
2,761 $379,000
Q2 2022

Aug 09, 2022

BUY
$181.58 - $368.0 $5.09 Million - $10.3 Million
28,047 New
28,047 $5.17 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $4.19 Million - $5.84 Million
-13,780 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$347.28 - $421.83 $136,481 - $165,779
-393 Reduced 2.77%
13,780 $5.24 Million
Q3 2021

Nov 09, 2021

BUY
$405.61 - $524.84 $5.75 Million - $7.44 Million
14,173 New
14,173 $5.75 Million
Q2 2021

Aug 12, 2021

SELL
$372.84 - $481.5 $4.31 Million - $5.57 Million
-11,558 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$361.28 - $504.76 $3.36 Million - $4.7 Million
9,306 Added 413.23%
11,558 $4.44 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $659,160 - $835,401
2,252 New
2,252 $833,000
Q1 2019

May 13, 2019

SELL
$272.57 - $321.18 $1.69 Million - $1.99 Million
-6,200 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$272.46 - $366.54 $1.69 Million - $2.27 Million
6,200 New
6,200 $1.86 Million
Q3 2018

Nov 13, 2018

SELL
$279.04 - $367.06 $425,256 - $559,399
-1,524 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $536,655 - $686,948
-2,352 Reduced 60.68%
1,524 $425,000
Q1 2018

May 11, 2018

BUY
$209.54 - $253.91 $812,177 - $984,155
3,876 New
3,876 $916,000
Q4 2017

Feb 12, 2018

SELL
$202.23 - $230.03 $536,718 - $610,499
-2,654 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$172.3 - $213.93 $457,284 - $567,770
2,654
2,654 $528,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $16.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.